Oncolytics Biotech Inc. Held Special Shareholder Meeting

Reuters
2026.01.15 21:01
portai
I'm PortAI, I can summarize articles.

Oncolytics Biotech Inc. held a Special Meeting of Shareholders on January 15, 2026, where shareholders approved the company's continuance from Alberta to British Columbia, and then to Nevada. They also approved the Oncolytics Biotech Inc. 2026 Incentive Award Plan, contingent on the completion of these changes.

Oncolytics Biotech Inc. held a Special Meeting of Shareholders on January 15, 2026. Shareholders approved a proposal to continue the company from the Province of Alberta to the Province of British Columbia in Canada, and another proposal to continue the company from the Province of British Columbia to the State of Nevada in the United States. In addition, shareholders approved the implementation of the Oncolytics Biotech Inc. 2026 Incentive Award Plan, conditional upon completion of the continuance and domestication. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oncolytics Biotech Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 9626679) on January 15, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.